Varicella Zoster Virus: Interferon Production and Comparative
Interferon Sensitivity in Human Cell Cultures
Interferon has been demonstrated to be present in vesicles of persons infected with chickenpox and herpes zoster viruses (Wheelock, i967; Armstrong et al. 197o ). Using human foreskin fibroblast monolayers, our studies demonstrate that varicella zoster infection results in interferon production and that interferon or polyinosinic acid: polycytidylic acid (Poly I: C) pre-treatment protects these cell cultures from varicella zoster virus infection.
Varicella zoster virus (ELLEN strain, supplied by Dr P. Brunell) was grown on human foreskin fibroblast (I-IFF) monolayers using Minimal Eagle's media (MEM) and 2 ~o inactivated foetal calf serum. Varicella zoster virus infection was passed using intact, infected cells. Vesicular stomatitis virus (VSV, INDIANA strain, supply by Dr L. Glasgow and Dr S. Baron) and vaccinia virus (IHD strain, Wyeth) were similarly cultured. Media for interferon assay from virus-infected HFF monolayers was collected by aspiration and centrifuged for 2 hr at Ioo,ooog. The assay was performed on HFF cells using VSV challenge; the interferon titre was expressed as the reciprocal of the dilution reducing the plaque formation by 5o % (Merigan, Gregory & Petralli, I966 ).
To assay the sensitivity of varicella zoster virus to interferon or (Poly I: C), HFF monolayers were grown in microculture plates (Falcon Plastics, Los Angeles). Media was removed from 2-day-old confluent cells and replaced with media containing standard human interferon (Merigan et al. 1966) or Poly I: C and incubated for 24 hr before virus challenge. Assay of the infection was made by counting microfoci of early cytopathic changes with a scanning lens at x 3oo magnification 2 days after the virus inoculation. Vaccinia virus or VSV was inoculated onto pre-treated monolayers in 5o mm. Petri dishes and overlaid with agar containing 5 ~o calf serum, and plaques were counted at 3 and 2 days, respectively, after staining with neutral red.
Three experiments were performed to assay interferon production by varicella zoster virus-infected cells. A heavy inoculum of virus was used, i.e. sufficient to cause Ioo% destruction of the monolayer in 3 or 4 days (approximately IO a to Io 4 p.f.u./plate). In each experiment Io to 3o units of interferon/4 ml. were detected within I2 to 24 hr of virus inoculation. The antivirus activity was confirmed to be human interferon in that (a) it was not sedimented by centrifugation at Ioo,ooog for 2 hr, (b) it was inactivated by incubation with o'25 mg./ml, trypsin (Difco) for I hr at 37 °, (c) it was not inactivated by holding at pH 2 at 4 ° for 48 hr, and (d) no activity was detected when assayed in mouse L cell monolayers.
A 50 % inhibition of varicella zoster virus microfoci formation was seen with 8 units of interferon using a small virus inoculum; using a three times larger inoculum there was a 50 % reduction of foci formation with 24 to 8o units of interferon. A 50 ~o plaque reduction was seen with 8 units of interferon against vaccinia, and between o.8 and 2"4 units against VSV (Table I) .
Fifty per cent reduction of microfoci was seen with o.ool to o.oi/zg./ml, of Poly I:C against a small inoculum, and with a 3 times larger inoculum o.oI to o-I/~g,/ml, was needed (Table 2) . VSV was more sensitive, requiring only o.ooI/~g./ml.
Caunt & Taylor-Robinson (I964) failed to detect interferon production by varicella zoster virus infected amnion or thyroid cell monolayers when the supernatant media was assayed from 4 to 20 days after virus inoculation. Our observation of interferon production within 24 hr after inoculation might be due to our experimental design permitting a more rapidly evolving infection. Possible explanations for their failure to demonstrate interferon production migbt also include their use of different cell lines, the timing of their supernatant collections, or perhaps a lack of sensitivity of their interferon assay methods. The varicella zoster virus appeared somewhat less sensitive to interferon than VSV, but comparable to vaccinia virus. Its interferon sensitivity appeared related to virus inoculum size, a phenomenon previously commented on by Finter (1966) . 
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